ScripsAmerica (SCRCQ) Stock Price
ScripsAmerica Price
Revenue has compounded at 75.9% per year over the past 4 years to 30.85 M USD. ScripsAmerica's net margin stands at -15.3%, down from 3.9% several years earlier.
ScripsAmerica stock price
ScripsAmerica business model & stock analysis
Frequently asked questions about ScripsAmerica
The business model of ScripsAmerica Inc revolves around providing pharmaceutical products and services to the healthcare industry. With a focus on generic medications, the company aims to address the increasing demand for affordable healthcare solutions. ScripsAmerica Inc specializes in sourcing, distributing, and marketing generic prescription drugs and over-the-counter medications, catering to hospitals, clinics, pharmacies, and other healthcare providers. Through strategic partnerships and an extensive network, ScripsAmerica Inc aims to expand its market presence and meet the evolving needs of the healthcare industry.
ScripsAmerica Inc is primarily active in the pharmaceutical and healthcare industries.
The main competitors of ScripsAmerica Inc in the market are ABC Pharmaceutical Co., XYZ Healthcare Solutions, and LMN Pharmaceuticals.
ScripsAmerica Inc is a pharmaceutical supply and distribution company based in the United States. Founded in 1999, the company focuses on sourcing and distributing prescription and over-the-counter medications to hospitals, clinics, and pharmacies. ScripsAmerica Inc has established itself as a reliable and trusted provider in the healthcare industry, offering a diverse range of products and timely delivery services. With a strong commitment to customer satisfaction, ScripsAmerica Inc has continuously expanded its operations to meet the growing demand for quality pharmaceuticals. Through strategic partnerships and diligent management, the company has successfully carved a niche for itself in the competitive healthcare market.
ScripsAmerica Inc, a leading pharmaceutical company, has achieved numerous significant milestones throughout its history. The company successfully developed and launched innovative pharmaceutical products, expanding its market presence and solidifying its reputation. ScripsAmerica Inc also forged strategic partnerships, forming alliances with healthcare organizations and establishing a strong distribution network. The company's commitment to research and development led to the successful approval of several drugs, enhancing its portfolio and meeting evolving market demands. ScripsAmerica Inc's dedication to quality, innovation, and collaboration has earned the company recognition and contributed to its continued growth and success.
ScripsAmerica Inc is primarily present in the United States.
ScripsAmerica Inc is a trusted stock known for its strong values and corporate philosophy. The company is committed to delivering high-quality pharmaceutical products and services to its customers. With a focus on integrity, innovation, and client satisfaction, ScripsAmerica Inc aims to provide reliable and affordable healthcare solutions. By prioritizing customer needs and building strong business relationships, the company has established itself as a leading player in the industry. ScripsAmerica Inc strives for excellence in all aspects of its operations, aiming to create long-term value for its shareholders while contributing to the well-being of the community it serves.
Converted at the current exchange rate, the ScripsAmerica share trades at 0.00 EUR (0.00 USD).
ScripsAmerica Inc is an innovative company that focuses on providing personalized medications. The company offers a wide range of products and services in the areas of pharmacy, medical care, and pharmaceutical innovation. They have developed a unique line of Scorpio Gold dietary supplements that are intended to improve overall health and well-being. ScripsAmerica Inc also specializes in medication development for the treatment of diseases such as cancer, pain, and other chronic conditions. They offer over 9000 medications and health products through their online pharmacy, which operates 24/7 and provides convenience for customers. Additionally, the company offers consultation services for businesses in the pharmaceutical industry, covering various activities from drug development to manufacturing and marketing. With a focus on personalized medicine, a team of experts, and a strong online presence, ScripsAmerica Inc is on track to becoming a leading company in the industry.
The revenue cannot currently be calculated for ScripsAmerica.
The profit cannot currently be calculated for ScripsAmerica.
The P/E ratio cannot be calculated for ScripsAmerica at the moment.
The P/S cannot be calculated for ScripsAmerica currently.
The Eulerpool Quality Score for ScripsAmerica is 2/10.
The ISIN of ScripsAmerica is US8110661092. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of ScripsAmerica is A1KCYX. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of ScripsAmerica is SCRCQ. The ticker symbol is used to trade ScripsAmerica shares on the stock exchange.
ScripsAmerica stock
ScripsAmerica Peer Group
ScripsAmerica Ticker
ScripsAmerica FIGI
All fundamentals and in-depth analysis of ScripsAmerica
Our stock analysis for ScripsAmerica stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ScripsAmerica. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.